Victory Capital Management Inc Sarepta Therapeutics, Inc. Transaction History

Victory Capital Management Inc

$98.4 Billion
Q1 2024

A detailed history of Victory Capital Management Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 71,986 shares of SRPT stock, worth $11.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

71,986

Previous 75,032 4.06%

Holding current value

$11.4 Million

Previous $7.24 Million 28.8%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$93.7 - $141.53 $285,410 - $431,100	-3,046 Reduced 4.06%	71,986 $9.32 Million
Q4 2023 Feb 05, 2024	SELL	$67.31 - $124.76 $831,547 - $1.54 Million	-12,354 Reduced 14.14%	75,032 $7.24 Million
Q3 2023 Nov 06, 2023	BUY	$102.5 - $123.59 $1.32 Million - $1.59 Million	12,894 Added 17.31%	87,386 $10.6 Million
Q2 2023 Jul 27, 2023	SELL	$106.4 - $157.19 $333,564 - $492,790	-3,135 Reduced 4.04%	74,492 $8.53 Million
Q1 2023 May 02, 2023	BUY	$117.53 - $155.99 $2.39 Million - $3.17 Million	20,350 Added 35.53%	77,627 $10.7 Million

Q4 2022 Feb 10, 2023	BUY	$100.86 - $132.13 $8,573 - $11,231	85 Added 0.15%	57,277 $7.42 Million
Q4 2022 Feb 09, 2023	SELL	$100.86 - $132.13 $14 Million - $18.4 Million	-139,262 Reduced 70.89%	57,192 $7.41 Million
Q3 2022 Nov 02, 2022	BUY	$75.71 - $119.24 $12.2 Million - $19.2 Million	160,708 Added 449.58%	196,454 $21.7 Million
Q2 2022 Aug 01, 2022	SELL	$62.69 - $88.44 $1.09 Million - $1.53 Million	-17,322 Reduced 32.64%	35,746 $2.68 Million
Q1 2022 May 04, 2022	SELL	$63.15 - $90.42 $36.6 Million - $52.4 Million	-579,212 Reduced 91.61%	53,068 $4.08 Million
Q4 2021 Feb 07, 2022	BUY	$77.28 - $99.42 $48 Million - $61.8 Million	621,740 Added 5898.86%	632,280 $56.9 Million
Q3 2021 Nov 02, 2021	BUY	$65.97 - $92.48 $40,241 - $56,412	610 Added 6.14%	10,540 $975,000
Q2 2021 Aug 03, 2021	SELL	$69.38 - $86.75 $9,296 - $11,624	-134 Reduced 1.33%	9,930 $772,000
Q1 2021 May 04, 2021	SELL	$72.25 - $168.95 $1.4 Million - $3.27 Million	-19,342 Reduced 65.78%	10,064 $750,000
Q4 2020 Feb 01, 2021	SELL	$125.56 - $178.74 $439,711 - $625,947	-3,502 Reduced 10.64%	29,406 $5.01 Million
Q3 2020 Nov 09, 2020	BUY	$127.12 - $172.34 $2.75 Million - $3.73 Million	21,631 Added 191.82%	32,908 $4.62 Million
Q2 2020 Aug 07, 2020	SELL	$93.0 - $171.7 $13,671 - $25,239	-147 Reduced 1.29%	11,277 $1.81 Million
Q1 2020 May 04, 2020	SELL	$82.38 - $131.64 $3,295 - $5,265	-40 Reduced 0.35%	11,424 $1.12 Million
Q4 2019 Feb 06, 2020	BUY	$76.53 - $135.58 $68,647 - $121,615	897 Added 8.49%	11,464 $1.48 Million
Q4 2019 Feb 04, 2020	SELL	$76.53 - $135.58 $90,534 - $160,391	-1,183 Reduced 10.07%	10,567 $1.23 Million
Q3 2019 Nov 12, 2019	BUY	$72.81 - $156.91 $855,517 - $1.84 Million	11,750 New	11,750 $885,000

Others Institutions Holding SRPT

# of Institutions

470

Shares Held

79.3M

Call Options Held

4.23M

Put Options Held

1.21M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $13.8B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Sarepta Therapeutics, Inc. Transaction History